I rise today against this rule. Members should have an opportunity to vote on an enhanced version of the bipartisan Senate bill. That is the Blue Dog prescription drug benefit bill. Unfortunately for seniors across this country, our friends across the aisle have disallowed a debate on this better bill. It is better because it has a guaranteed fall-back, which means if seniors cannot get a PPO, they will have Medicare. It is better because there are no premium supports, which means seniors are not going to be penalize for staying in Medicare; and it is better because it does not privatize Medicare. Medicare is an important program that has saved the lives of many seniors, and an inclusion of a prescription drug benefit deserves an open debate. Mr. Speaker, I urge opposition to this rule so the Blue Dog proposal can be debated and seniors can have the best coverage that we can afford at this time. Mr. Speaker, today I rise in opposition to the rule of the Republican Medicare Prescription Drug Bill, H.R. 1. It serves only one purpose-- ensuring that the voices of several in the Democratic Party are never heard on this critical issue.
Mike Thompson: “I rise today against this rule. Members should have an opportunity to vote on an enhanced version of the bipartisan…”
On the recordJune 26, 2003
Source
govinfo.govEditor's note · Context
Opposing the Republican Medicare Prescription Drug Bill and advocating for the Blue Dog prescription drug benefit bill.
Share
More from Mike Thompson
Feb 12, 2026
for folks who make the argument that people are afraid, they want to have the newest taser technology to keep themselves safe in the civilian space, I understand that. They are not precluded from being able to purchase and have this new…
Apr 9, 2024
These families should not have their assets, which are necessary to do their jobs and feed our Nation counted against them.
May 29, 2026
In the wake of losing their homes and livelihoods, it is wrong to tax survivors on settlement money that is meant to help them rebuild their lives.





